Business:
Radiopharmaceuticals
Drug notes:
5+ additional undisclosed programs RD/Clin0 multiple cancers, undisclosed
About:
Alpha-9 Theranostics is a clinical stage company developing highly selective, peptide-based radiopharmaceuticals for cancer treatment. Their treatments are developed with a binder, linker, chelator, and radioisotope, giving them high selectivity for delivering radiation to cancer cells with minimal off-target effects. Their developed molecules are optimized for imaging, dosimetry, and therapy studies to evaluate the tumor uptake and dose delivery, as well as determine the optimal patient population. Alpha-9 Theranostics was founded in 2019 by researchers in British Columbia to improve the lives of people with metastatic cancers. Alpha-9 Theranostics’ new research facility in Vancouver was completed in 2023, housing chemistry, biology, and radiochemistry R&D teams to accelerate their discovery efforts.
Associate Scientist II/III, Radiochemistry Vancouver, British Columbia, Canada|32 days ago
Principal Scientist Dx CMC Radiochemistry Vancouver, British Columbia, Canada|34 days ago
Manager/Senior Manager Human Resources Operations ... Vancouver, British Columbia, Canada|34 days ago
Associate Director/Director, Corporate Strategy Boston, MA|34 days ago
Safety Manager Vancouver, British Columbia, Canada|35 days ago
Principal Scientist/Associate Director, Translatio... Vancouver, British Columbia, Canada|35 days ago
Associate Director, Intellectual Property Boston, MA|Not provided